Programs

Programs

Scroll To Explore

Immuno-Oncology

  • A2aR/A2bR antagonist for immuno-oncology

    Discover
  • EP4R antagonist for immuno-oncology

    Discover
  • First-in-class anti-GPCR antibody for immuno-oncology

    Discover

CNS and Rare diseases

  • mGluR4/7/8 positive allosteric modulator for Parkinson’s disease

    Discover
  • NPFFR small molecule antagonist to combat the opioid crisis

    Discover
  • Orphan GPCRs for Central Nervous System (CNS) disease area

    Discover
  • PAR2 negative allosteric modulator for rare inflammatory diseases

    Discover
  • MC4R pharmacochaperone for the treatment of early onset obesity

    Discover
  • New GPCRs target identification and validation

    Discover

Participation portfolio

  • First-in-class CXCR4 agonist to control auto-immune diseases

    Discover
  • Sema3A fusion protein for immuno-oncology

    Discover
  • undisclosed targets

    Discover
Partnerships
Partnering with us